Skip to main content

Regenerx Biopharmaceuticals Inc

RGRXDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0000707511

Regenerx Biopharmaceuticals Inc was delisted in 2023; its insiders filed their last Form 4 on Jul 6, 2023; 1 institution reported holding it in 13F filings for Q3 2023, worth $170 in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Regenerx Biopharmaceuticals Inc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of RGRX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders110
Shares10.0K10.0K0 (0.0%)
Value$266$170−$96 (−36.1%)

New holders (0)

Institutions that held Regenerx Biopharmaceuticals Inc at the end of Q3 2023 but not at the end of Q2 2023.

None.

Sold out (0)

Institutions that held Regenerx Biopharmaceuticals Inc at the end of Q2 2023 and filed for Q3 2023 without it.

None.